Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 19/12/20121 min de lecture
Impact of Approved Drug Labeling on Chronic Opioid Therapy; Public Hearing; Request for Comments
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →